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Abstract
Background: Dilated cardiomyopathy (DCM) in children is an important cause of severe heart failure and carries a 
poor prognosis. Adults with heart failure are at increased risk of anxiety and depression and such symptoms predict 
adverse clinical outcomes such as mortality. In children with DCM, studies examining these associations are scarce.
Aims: We studied whether in children with DCM: (1) the level of emotional and behavioral problems was increased as 
compared to normative data, and (2) depressive and anxiety problems were associated with the combined risk of death 
or cardiac transplantation.
Methods: To assess emotional and behavioral problems in children with DCM, parents of 68 children, aged 1.5–18 years 
(6.9±5.7 years), completed the Child Behavior Checklist.
Results: Compared to normative data, more young children (1.5–5 years) with DCM had somatic complaints (24.3% vs. 
8.0%; p < .001), but fewer had externalizing problems (5.4% vs. 17.0%; p = .049). Overall internalizing problems did not 
reach significance. Compared to normative data, more older children (6–18 years) showed internalizing problems (38.7% 
vs. 17.0%; p = .001), including depressive (29.0% vs. 8.0%; p < .001) and anxiety problems (19.4% vs. 8.0%; p = .023), and 
somatic complaints (29.0% vs. 8.0%; p < .001). Anxiety and depressive problems, corrected for heart failure severity, did 
not predict the risk of death or cardiac transplantation.
Conclusion: Children of 6 years and older showed more depressive and anxiety problems than the normative population. 
Moreover, in both age groups, somatic problems were common. No association with outcome could be demonstrated.
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Introduction
Cardiomyopathies are disorders characterized by struc-
tural and functional abnormalities of the heart. The most 
common subtype in children is dilated cardiomyopathy 
(DCM), accounting for approximately 60% of pediatric 
cardiomyopathies.1,2 DCM, which is characterized by 
impaired systolic function and dilation of the left ventri-
cle,3 is estimated to affect 0.57 per 100,000 children annu-
ally.4 Though disease presentation can vary greatly, 80% 
of patients show symptoms related to heart failure, such as 
fatigue, orthopnea, edema, and excessive sweating. 
Symptoms can also include circulatory collapse, arrhyth-
mias, thromboembolic events, and sudden death.5 Although 
some children recover,6 the prognosis of DCM generally is 
poor: within 2 years after diagnosis, approximately 40% of 
children die or undergo cardiac transplantation,4,6–8 mak-
ing DCM the leading indication for cardiac transplantation 
worldwide.9–11 Considering the symptoms and prognosis 
of DCM, substantial effects on psychosocial wellbeing can 
be expected.12
Compelling evidence from two meta-analyses shows 
that adults with heart failure are at increased risk of anxi-
ety and depression.13,14 Few studies have examined the 
psychosocial wellbeing of children with DCM, but, indeed, 
it has been found that children with DCM have a lower 
health-related quality of life (HRQoL) than healthy chil-
dren.12,15–18 However, studies examining emotional and 
behavioral problems in children with DCM are scarce. 
Moreover, the currently available studies have small sam-
ple sizes (n ⩽ 15) and show contradictory results. In a 
cross-sectional study, half (n = 6 out of 12) of children 
with cardiomyopathy listed for cardiac transplantation 
showed clinically significant overall emotional and behav-
ioral problems.19 In contrast, a study examining depressive 
symptoms in children with DCM (n = 15) did not find 
higher rates of symptoms compared with healthy chil-
dren.20 However, it should be noted that these studies used 
different questionnaires.
Regarding the impact of impaired HRQoL on cardiac 
outcomes, two studies have shown that children’s physical 
HRQoL (reported by parents) predicts mortality and car-
diac transplantation, independent from heart failure sever-
ity.15,17 Also, a meta-analysis and reviews have consistently 
found that depressive and anxiety symptoms in adults with 
heart failure predict mortality and other adverse clinical 
outcomes,13,21,22 such as hospitalization and arrhythmias. 
However, to the best of our knowledge, the predictive 
value of depressive and anxiety symptoms in children with 
DCM has not been previously studied. Information on the 
predictive value of depressive and anxiety symptoms may 
be valuable for clinical management strategies. Depressive 
and anxiety problems may lead to poorer self-care and, in 
turn, to disease progression.22
The aim of the present study was twofold: firstly, we 
evaluated the level of parent-reported emotional and 
behavioral problems in children with DCM compared 
with the general population. Secondly, we exploratively 
examined whether the level of parent-reported anxiety 
and depressive problems predicted the combined risk of 
death and cardiac transplantation whilst controlling for 
heart failure severity. Based on the aforementioned adult 
studies, we hypothesized that children with DCM would 
show more anxiety and depressive problems than children 
in the general population. Moreover, we hypothesized that 
anxiety and depressive problems would predict mortality 
in children with DCM independent from heart failure 
severity.
Material and methods
All data used in this observational, cross-sectional study 
were derived from a larger multicenter longitudinal study 
in children with heart failure secondary to cardiomyopa-
thy.15 The study protocol was approved by the Medical 
Ethics Committee of the Erasmus Medical Center (proto-
col number NL45663.078) and by the institutional review 
boards of all participating centers. The study performed 
conformed to the ethical guidelines of the Declaration of 
Helsinki,23 and reported following the STROBE state-
ment. Before participation, written informed consent was 
obtained from all patients’ parents or legal guardians and 
from all patients aged 12 years or above.
Participants
Participants were recruited from October 1, 2010 to 
November 1, 2015 through seven tertiary centers for pedi-
atric cardiology in the Netherlands. The database was 
closed on July 1, 2017. Children were eligible to partici-
pate if they had heart failure secondary to DCM. DCM was 
defined as fractional shortening ⩽25% and left ventricular 
end-diastolic dimension z-score > 2 for body surface area. 
DCM could be idiopathic or secondary to other causes. 
Exclusion criteria were known mental retardation, con-
genital heart disease, neuromuscular disease, and insuffi-
cient mastery of the Dutch language by parents. In the 
current study, we only included 1.5–18-year-old children 
due to age restrictions of the used questionnaire. Since age 
and gender-matched normative data on emotional and 
behavioral problems is available, we did not recruit a 
healthy control group.24
Procedure
Children were either included at DCM diagnosis or were 
included at an outpatient appointment for a previously diag-
nosed DCM in one of the participating tertiary pediatric car-
diology centers. Demographic variables were obtained at 
inclusion. Socioeconomic status was based on the highest of 
both parents’ occupations and categorized into low, low to 
middle, middle, or high according to the international 
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classification system.25 Parents were asked to complete a 
questionnaire assessing their child’s emotional and behavio-
ral problems during an outpatient clinic visit. During the 
same visit, a pediatric cardiologist completed the New York 
University Pediatric Heart Failure Index (NYU PHFI).26 
This validated index assesses heart failure severity based on 
symptoms and medication use. Scores range from 0 to 30. A 
higher score indicates more severe heart failure.
Emotional and behavioral problems
One of each participant’s parents completed the problem 
section of the Child Behavior Checklist (CBCL).27 
Depending on the child’s age, the CBCL 1½–5 (100 items; 
children aged 1.5–5 years) or the CBCL/6–18 (120 items; 
children aged 6–18 years) was completed. For both ver-
sions, response categories range from 0 (not true) to 2 (very 
true or often true). The CBCL assesses overall emotional 
and behavioral problems and specific aspects of mental 
health and problem behavior. In addition to an overall total 
problem score, broadband scale scores can be calculated 
for externalizing problems (i.e. externally directed prob-
lems affecting the environment, such as aggression and 
delinquency) and internalizing problems (i.e. internally 
directed problems such as depression, anxiety, and somatic 
complaints). Furthermore, the CBCL 1½–5 consists of five 
scales based on the fifth edition of the Diagnostic and 
Statistical Manual of Mental Disorders (DSM-5; i.e. 
depressive problems, anxiety problems, attention deficit/
hyperactivity problems, oppositional defiant problems, and 
autism spectrum problems). In addition, seven empirical 
scales can be calculated (i.e. anxious/depressed, somatic 
complaints, attention problems, aggressive behavior, emo-
tionally reactive, withdrawn, and sleep problems). The 
CBCL/6–18 consists of six DSM-5 based scales (i.e. 
depressive symptoms, anxiety problems, somatic prob-
lems, attention deficit/hyperactivity problems, oppositional 
defiant problems, and conduct problems) and eight empiri-
cal scales (i.e. anxious/depressed, withdrawn/depressed, 
somatic complaints, social problems, thought problems, 
attention problems, rule-breaking behavior, and aggressive 
behavior). On all scales, higher scores indicate more prob-
lems. For each scale, scores can be interpreted as falling in 
the normal, borderline, or clinical range by comparing scale 
scores with norm data. Scores in the borderline or clinical 
range indicate psychopathological problems with a need 
for clinical follow-up and/or intervention. The CBCL has 
adequate psychometric properties and normative data from 
the Dutch general population are available.24
Endpoint
We used a combined endpoint of death and cardiac trans-
plantation. Information on mortality and cardiac transplan-
tation was retrieved from patient records. Follow-up was 
censored at July 1, 2017.
Statistical analyses
Firstly, we examined whether the proportion of children 
scoring in the borderline or clinical range of emotional and 
behavioral problems was larger in our DCM study popula-
tion than in the general population. All raw scale scores 
were converted to percentiles using the Achenbach System 
of Empirically Based Assessment Standard norm data, 
which is based on data of Dutch children from the general 
population and accounts for age and gender.27 Conforming 
with the CBCL manual,27 for the total problems scale, 
internalizing problems scale, and externalizing problems 
scale, percentile scores of 83 or lower were defined as non-
clinical and percentile scores of 84 or higher were defined 
as borderline/clinical. For the DSM scales and empirical 
scales, percentile scores of 92 or lower were defined as 
non-clinical and percentile scores of 93 or higher were 
defined as borderline/clinical. One sample binomial tests 
were conducted for each scale of the CBCL 1½–5 and the 
CBCL/6–18 to test whether the proportion of children with 
DCM scoring in the borderline/clinical range was higher 
than the proportion in the norm group.
Secondly, we conducted a Cox regression analysis to 
examine whether anxiety and depressive problems pre-
dicted the combined endpoint of death and cardiac trans-
plantation whilst controlling for heart failure severity. The 
covariates entered into the model were the CBCL scale 
scores for anxiety problems and depressive problems and 
the NYU PHFI. We used t-scores to account for differ-
ences between the two versions of the CBCL (i.e. CBCL 
1½–5 and CBCL/6-18) anxiety problems and depressive 
problems scale scores. The NYU PHFI was added to the 
model because heart failure severity is a known predictor 
of mortality.15 All analyses were performed using SPSS 
Statistics version 24.0.28
Results
In total, 144 children with DCM participated in the larger 
multicenter longitudinal study in children with heart fail-
ure secondary to cardiomyopathy from which data for the 
current study was derived. Of this group, 52 children were 
excluded from participation in the current study (N = 26 
had a too short follow-up period to fill out the CBCL, N = 
14 were younger than 1.5 years, N = 7 had a neuromuscu-
lar disease, N = 5 did not master the Dutch language suf-
ficiently). Therefore, 92 children met the eligibility criteria 
for the current study, 68 of whom consented to participate 
in the current study (see Figure 1). Participant characteris-
tics are presented in Table 1.
Emotional and behvaioral problems compared 
with the general population
1.5- to 5-year-old children (CBCL 1½–5). The proportion of 
parent-reported emotional and behavioral problems in 
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Figure 1. Participation flowchart.
Table 1. Participant characteristics.
Characteristic Overall group (N = 68) Did not reach endpoint (N = 57) Reached endpoint (N = 11)
1.5–5 years  
(N = 37)
6–18 years  
(N = 31)
1.5–5 years  
(N = 31)




6–18 years  
(N = 5)
Male gender, N (%) 20 (54.1%) 17 (54.8%) 18 (58.1%) 16 (61.5%) 2 (33.3%) 1 (20.0%)
Age in years, M (SD) 2.2 (1.3) 12.4 (3.5) 2.0 (0.5) 12.5 (3.6) 3.3 (1.2) 11.8 (3.4)
Time since DCM 
diagnosis in months, 
median (IQR)
19.0 (12.0–36.0) 57.0 (24.0–107.0) 18.0 (12.0–24.0) 58.5 (27.0–110.0) 40.5 (24.5–59.0) 24.0 (17.0–73.5)
NYU PHFI, M (SD) 6.3 (4.8) 7.2 (3.8) 4.8 (3.2) 5.5 (3.1) 14.2 (3.9) 12.6 (2.1)
Socioeconomic statusa, N (%)
Low 1 (2.7%) 2 (6.5%) 1 (3.2%) 2 (7.7%) 0 (0.0%) 0 (0.0%)
Low to middle 10 (27.0%) 10 (32.3%) 8 (25.8%) 10 (38.5%) 2 (33.3%) 0 (0.0%)
Middle 3 (8.1%) 6 (19.4%) 3 (9.7%) 6 (23.1%) 0 (0.0%) 0 (0.0%)
High 16 (43.2%) 10 (32.3%) 13 (41.9%) 5 (19.2%) 3 (50.0%) 5 (100.0%)
Missing 7 (18.9%) 3 (9.7%) 6 (19.4%) 3 (11.5%) 1 (16.7%) 0 (0.0%)
IQR = Interquartile range; NYU PHFI = New York University Pediatric Heart Failure Index.
aSocioeconomic status was determined by parents’ occupation level.25
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1.5- to 5-year-old children with DCM and children in the 
norm group is shown in Table 2. The CBCL 1½–5 was 
completed for 37 participants (by N = 9 fathers, N = 25 
mothers, N = 3 parents together) at a median time of 19.0 
months after DCM diagnosis (range 10.0–65.0 months; 
see Table 1). Compared with the normative data of same-
aged children (8.0% borderline or clinical score), a signifi-
cantly larger proportion of children with DCM (24.0% 
borderline or clinical score) showed somatic complaints in 
the borderline or clinical range, p < .001. In contrast, the 
proportion of children showing a borderline or clinical 
level of externalizing problems was significantly smaller 
in the DCM study group (5.4% clinical or borderline score) 
than in the general population (17.0% borderline or clini-
cal score), p = .049.
For the other scales, the proportions of borderline and 
clinical problems in children with DCM and children from 
the general population did not significantly differ. However, 
trends towards significance were found for more emotion-
ally reactive (p = .062) and depressive problems (p = .062), 
and less attention deficit/hyperactivity problems (p = .068).
Six- to 18-year-old children (CBCL/6–18). The distribution of 
parent-reported emotional and behavioral problems in 6- 
to 18-year-old children with DCM and children from the 
general population is shown in Table 3. The CBCL/6–18 
was completed for 31 children (by N = 5 fathers, N = 23 
mothers, N = 3 parents together) at a median time of 39.0 
months after DCM diagnosis (range 12.0–177.0 months; 
see Table 1). Compared with normative data of same-aged 
peers, significantly larger proportions of children with 
DCM showed problems in the borderline or clinical range 
on the following scales: internalizing problems (p = .001; 
17.0% vs. 38.7%), anxious/depressed problems (p = .023; 
8.0% vs. 19.4%), somatic complaints (p < .001; 8.0% vs. 
29.0%), depressive problems (p < .001; 8.0% vs. 29.0%), 
anxiety problems (p = .023; 8.0% vs. 19.4%), and somatic 
problems (p < .001; 8.0% vs. 25.8%). For the other scales, 
the proportion of borderline and clinical problems did not 
significantly differ between children with DCM and chil-
dren from the general population.
Predictive value of anxiety and depressive 
problems on endpoint
We examined whether anxiety and depressive symptoms 
predicted the combined risk of death or cardiac transplan-
tation whilst controlling for NYU PHFI. The proportional 
hazard assumptions were not violated. Before July 1, 2017, 
11 participants (16.2%) had reached an endpoint. One had 
died and 10 had undergone cardiac transplantation. The 
results of the Cox regression analysis are presented in 
Table 4. Anxiety problems and depressive problems did 
not significantly predict death or cardiac transplantation. 
However, the NYU PHFI did significantly predict the risk 
of death or cardiac transplantation, p < .001. A one unit 
Table 2. Distribution of non-clinical versus borderline/clinical emotional and behavioral problems reported by parents of 1.5- to 
5-year-old children (CBCL 1½–5).
CBCL 1½–5 scale DCM patients (N = 37)a General population p-value
Non-clinical, N (%) Borderline/clinical, N (%) Non-clinical % Borderline/clinical %
Broadband scales
Internalizing problems 29 (78.4%) 8 (21.6%) 83% 17% .298
Externalizing problems 35 (94.6%) 2 (5.4%) 83% 17% .049
Total problems 31 (83.8%) 6 (16.2%) 83% 17% .500
Syndrome scales
Anxious/depressed 36 (97.3%) 1 (2.7%) 92% 8% .188
Somatic complaints 28 (75.7%) 9 (24.3%) 92% 8% < .001
Attention problems 36 (97.3%) 1 (2.7%) 92% 8% .188
Aggressive behavior 35 (94.6%) 2 (5.4%) 92% 8% .390
Emotionally reactive 31 (83.8%) 6 (16.2%) 92% 8% .062
Withdrawn 33 (89.2%) 4 (10.8%) 92% 8% .372
Sleep problems 34 (91.9%) 3 (8.1%) 92% 8% .500
DSM-oriented scales
Depressive problems 31 (83.8%) 6 (16.2%) 92% 8% .062
Anxiety problems 32 (86.5%) 5 (13.5%) 92% 8% .175
Attention deficit/hyperactivity 
problems
37 (100%) 0 (0%) 92% 8% .068
Oppositional defiant problems 36 (97.3%) 1 (2.7%) 92% 8% .188
Autism spectrum problems 34 (91.9%) 3 (8.1%) 92% 8% .500
aReported by fathers (N = 9), mothers (N = 25), or both parents together (N = 3).
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increase in the NYU PHFI resulted in a 42% higher risk of 
death or cardiac transplantation (hazard ratio 1.42, 95% 
confidence interval 1.19–1.69).
Discussion
The current study is the first to investigate emotional and 
behavioral problems in a substantial cohort of children 
with DCM. Some results are in line with our expectations. 
Importantly, we found that, compared with normative data 
of same-aged peers, larger percentages of older children 
(6–18 years old) with DCM showed overall internalizing 
problems, anxiety problems, and depressive problems. 
Also, we found trends towards significance suggesting 
that, compared with normative data of same-aged peers, 
larger percentages of younger children (1.5–5 years old) 
with DCM showed emotionally reactive problems and 
depressive problems. These results are in line with meta-
analyses in adult heart failure populations, which demon-
strate an increased risk of anxiety and depression.13,14
Until now, only two studies have examined emotional 
and behavioral problems in children with DCM. The first 
study was conducted by Wray and Radley-Smith,19 who 
found that 50% of the children with cardiomyopathy in 
their study (N = 19, age 3½–17 years) showed a clinical 
level of overall emotional and behavioral problems on the 
CBCL questionnaire. In our study, this percentage was 
markedly lower (i.e. 10.8% in younger children and 16.1% 
in older children). This difference may be due to the fact 
that all children with cardiomyopathy in Wray and Radley-
Smith’s study were listed for cardiac transplantation, 
whereas in our study this was not the case.
In the second study, Menteer et al. compared the level 
of depressive symptoms in children (aged 7–21 years) with 
DCM (N = 15), children who had successfully undergone 
cardiac transplantation for heart failure (N = 23), and 
healthy children (N = 24).20 In contrast to our results, they 
found similar levels of depressive symptoms in all groups. 
That is, the level of depressive symptoms in children with 
DCM did not significantly differ from the level of depres-
sive symptoms in healthy children and children who had 
Table 3. Distribution of non-clinical versus borderline/clinical emotional and behavioral problems reported by parents of 6- to 
18-year-old children (CBCL/6–18).
CBCL/6–18 scale DCM patients (N = 31)a General population p-value





Internalizing problems 19 (61.3%) 12 (38.7%) 83% 17% .001
Externalizing problems 28 (90.3%) 3 (9.7%) 83% 17% .199
Total problems 26 (83.8%) 5 (16.1%) 83% 17% .500
Syndrome scales
Anxious/depressed 25 (80.6%) 6 (19.4%) 92% 8% .023
Withdrawn/depressed 28 (90.3%) 3 (9.7%) 92% 8% .495
Somatic complaints 22 (71.0%) 9 (29.0%) 92% 8% < .001
Social problems 28 (90.3%) 3 (9.7%) 92% 8% .495
Thought problems 26 (83.9%) 5 (16.1%) 92% 8% .091
Attention problems 27 (87.1%) 4 (12.9%) 92% 8% .250
Rule breaking behavior 31 (100%) 0 (0%) 92% 8% .095
Aggressive behavior 29 (93.5%) 2 (6.5%) 92% 8% .500
DSM-oriented scales
Depressive problems 22 (71.0%) 9 (29.0%) 92% 8% < .001
Anxiety problems 25 (80.6%) 6 (19.4%) 92% 8% .023
Somatic problems 23 (74.2%) 8 (25.8%) 92% 8% < .001
Attention deficit/hyperactivity problems 28 (90.3%) 3 (9.7%) 92% 8% .495
Oppositional defiant problems 28 (90.3%) 3 (9.7%) 92% 8% .495
Conduct problems 29 (93.5%) 2 (6.5%) 92% 8% .500
aReported by fathers (N = 5), mothers (N = 23), or both parents together (N = 3).
Table 4. Results of Cox regression analysis.
Variable HR 95% CI p-value
Lower Upper
Anxiety Problems (t-score) 0.98 0.89 1.09 .72
Depressive Problems (t-score) 0.98 0.88 1.08 .64
NYU PHFI (per unit) 1.42 1.19 1.69 < .001
CI = confidence interval; HR = hazard ratio; NYU PHFI = New York 
University Pediatric Heart Failure Index.
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undergone cardiac transplantation. However, it should be 
noted that Menteer and colleagues used small sample 
sizes, which limits the statistical power to detect differ-
ences between groups. Moreover, this discordance in 
results may be explained by the fact that we assessed 
depressive problems through the CBCL questionnaire 
whereas Menteer et al. used the Children’s Depression 
Inventory (CDI).29 Although both instruments assess 
depressive symptoms, previously, moderate correlations 
between CDI total scores and CBCL depressive problems 
scores have been found.30
Depressive and anxiety problems in children with DCM 
may be caused by factors directly or indirectly related to 
the illness. For example, in other chronic illnesses, it has 
been shown that the symptoms of the illness itself,31,32 and 
side effects of medical treatments,33 can provoke anxiety 
and depressive symptoms. More indirectly, illness uncer-
tainty (i.e. uncertainty regarding prognosis, disease course, 
and treatment) can increase symptoms of depression and 
anxiety.31,34 This can be explained by the cognitive coping 
theory,35 which states that children interpret situations 
based on previous knowledge and experiences. When such 
information is lacking, a situation may be interpreted as a 
threat, which consequently increases symptoms of depres-
sion and anxiety.31,36–39 Similarly, medical treatments such 
as injections may be experienced as distressing and threat-
ening, thereby increasing children’s anxiety levels.31 
Furthermore, it is known that parental overprotectiveness 
can promote anxiety and depressive symptoms in children 
with a chronic illness.31,34,40 Depressive and anxiety prob-
lems may also have a biological cause. In adult and pediat-
ric heart failure populations,41–43 reduced brain tissue 
volumes have been found in brain areas which regulate 
mood. Future research is needed to draw definite conclu-
sions as to biological causes of mood problems in DCM.
Besides increased anxiety and depressive problems, we 
demonstrated that, compared with normative data, a larger 
percentage of young and older children with DCM showed 
a borderline or clinical level of somatic problems. This is 
not surprising considering all children had heart failure 
problems secondary to DCM. Furthermore, previous stud-
ies have reported reduced levels of physical health related 
quality of life in this population.15
Other results of the current study were unexpected or 
contrary to our hypotheses. Firstly, we found that, com-
pared with normative data, a smaller percentage of 
young children with DCM showed a borderline or clini-
cal level of externalizing problems. In line with this 
result, we found a trend towards significance suggesting 
that, compared with normative data, a smaller percent-
age of young children with DCM showed attention defi-
cit/hyperactivity problems. This might be explained by 
increased levels of fatigue reported in DCM,5 which 
may contribute to children showing less hyperactive 
behavior.
Secondly, contrary to our hypothesis, we found that 
anxiety and depressive problems in children with DCM 
did not predict the risk of death and cardiac transplantation 
whilst controlling for heart failure severity. However, in 
line with the results of a previous DCM study, heart failure 
severity (NYU PHFI) did predict the risk of death and car-
diac transplantation.15 In contrast with our findings, in 
adult heart failure populations, a multitude of studies have 
shown that depressive problems predict mortality and 
other adverse clinical outcomes.13,21,44–48 Furthermore, 
increasing evidence shows that anxiety problems predict 
mortality in adult heart failure.22 An explanation for our 
different findings is that, in adults, depressive and anxiety 
problems can lead to poorer self-care.49 In children, how-
ever, parents may compensate for children’s poorer self-
care behaviors, which subsequently diminishes the impact 
of depressive and anxiety problems on their physical 
health. Also, it should be noted that statistical power to 
detect associations was limited.
This study has several strengths. Studies exclusively 
examining pediatric cardiomyopathy patients are scarce.12 
As stated, the current study is the first to examine emo-
tional and behavioral problems in a relatively large cohort 
of children with DCM. We recruited children with DCM 
through seven tertiary centers for pediatric cardiology. 
Also, we investigated problems in a broad age range (1.5–
18 years), using an internationally well-validated ques-
tionnaire (CBCL) to assess a wide range of emotional and 
behavioral problems. The multicenter recruitment and the 
inclusion of a broad age range improve the generalizability 
of our results in the pediatric DCM population. Moreover, 
we examined the predictive value of depressive and anxi-
ety problems on mortality and cardiac transplantation 
whilst controlling for heart failure severity, which is a 
known predictor of adverse outcomes. Furthermore, results 
from our study population were compared to representa-
tive normative data matched on age and gender.
The results of this study must also be interpreted in 
light of a few limitations. Firstly, although the study 
sample is relatively large considering the prevalence of 
DCM, the number of events in the study was 11, which 
limits the statistical power of the prediction analyses. 
Secondly, we only used proxy-reports completed by par-
ents because most participating children were too young 
to complete the self-report version of the CBCL.50 Of the 
children who were old enough to complete the self-
report version of the CBCL an insufficient number to 
analyze completed the questionnaire. The use of proxy-
reports has been frequently debated. Studies have found 
that parent proxy-reports of quality of life in pediatric 
cardiac populations may differ from child self-
reports.51,52 In another pediatric cardiac population, Patel 
and colleagues found that parent–child agreement was 
stronger for more readily observable variables such as 
physical functioning and externalizing behavior and 
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lower for variables which tend to be less visible,53 such 
as anxiety, emotional functioning, and internalizing 
behavior. In contrast, in a pediatric cardiac population, 
Marino and colleagues found that parent-proxy reports 
and child self-reports on quality of life did not differ.54 
Moreover, Wilmot and colleagues reported moderate 
parent–child agreement on quality of life of children 
with cardiomyopathy.16 Considering the scarcity of 
research into emotional and behavioral problems in chil-
dren with DCM, further research is needed using well-
attuned self-reports as well. Thirdly, we combined both 
father and mother reports in our analyses. Although this 
may induce bias,55 it should be noted that the majority of 
questionnaires were completed by mothers and previous 
research has found moderately high inter-parent agree-
ment on the CBCL.56 Fourthly, considering the relatively 
long period of time between DCM diagnosis and partici-
pation in the current study (see Table 1), it should be 
noted that the current cohort represents children with 
chronic heart failure. Children who reached an endpoint 
or recovered shortly after diagnosis are likely 
underrepresented.
In conclusion, this first study specifically examining 
emotional and behavioral problems of children with DCM 
showed, compared with normative data, significantly more 
borderline or clinical levels of anxiety, depressive prob-
lems, and somatic problems in 6–18-year-olds and signifi-
cantly more borderline or clinical somatic problems and 
less externalizing problems in 1.5–5-year-olds. These 
findings demonstrate the importance of including routine 
screening for internalizing problems to the clinical man-
agement of children with DCM,10 and of providing psy-
chosocial support attuned to the needs of these children. 
Considering the previously mentioned influence of paren-
tal behavior on anxiety and depressive symptoms in pedi-
atric chronic illness, such psychosocial support should not 
only focus on the children themselves but also include 
their parents. Future research should focus on evidence-
based psychosocial programs to treat and prevent internal-
izing problems in pediatric cardiomyopathy. As the 
available literature on emotional and behavioral wellbeing 
in pediatric cardiomyopathy is limited, many aspects 
remain to be studied. Considering previous adult studies 
and our findings, future research should focus on anxiety 
and depression in pediatric DCM. Moreover, as the results 
of our study show that emotional and behavioral problems 
in DCM seem to differ per age group, it would be useful to 
examine this in more age groups. Furthermore, a previous 
study found that HRQoL in children with DCM was more 
impaired at diagnosis than more than 1 year after diagno-
sis.15 Whether this is also the case for emotional and 
behavioral problems remains to be studied. Also, since lit-
tle is known about the psychosocial wellbeing of children 
with cardiomyopathy, future qualitative studies would be 
valuable.
Implications for Practice
•• Six- to 18-year-olds with dilated cardiomyopa-
thy showed more anxiety problems.
•• Six- to 18-year-olds with dilated cardiomyopa-
thy showed more depressive problems.
•• Children with dilated cardiomyopathy should be 
screened for internalizing problems.
•• Psychosocial support should be offered to chil-
dren with dilated cardiomyopathy.
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